Open Enrollment: Critical Time to Protect Your Health

You likely have an opportunity over the next few weeks to take more control over your health insurance. It’s “open enrollment” season for many Americans — the time when we can weigh our options and potentially switch health plans for the coming year.

Open enrollment offers a good opportunity to review your health insurance plan, make changes, or find a better one that works for your health — and your wallet — in 2017.

It’s critical that everyone — whether you’re healthy or not — take a moment to review your insurance options, even if your current plan has been serving you well. That’s because it may not be the same plan next year.

The nation’s two largest pharmacy benefit managers – Express Scripts and CVS/caremark, which set the coverage for many health insurers – recently announced additional drugs that they aren’t covering in 2017, bringing their total excluded products to 124 and 154, respectively.

Another reason why taking advantage of open enrollment is critical: Your health plan can even change after the new year begins.

In most states, there are no statutes requiring commercial health plans to honor their annual contracts with enrollees as it relates to pharmacy benefits. Your insurer is likely free — at any time — to move a drug to a higher tier (increasing your copay or making you jump through more hoops to get your medication) and even remove coverage of your treatment altogether.

Put another way, you’re locked into your health plan with the start of a new contract year, but your insurer isn’t required to provide the pharmacy benefits you signed up to receive.

Sometimes referred to as “non-medical switching,” these unforeseen insurance coverage changes can be devastating. I work with people living with HIV/AIDS who experience this reality, and it’s happening to many other insured Americans, especially those living with chronic health conditions.

These patients have worked with their physician to find an affordable therapy that keeps them stable, and then their insurance plan makes a coverage change that means they are switched to another drug altogether — potentially forcing them to face loss of disease control and even deal with debilitating side effects.

For people with epilepsy, for example, even the slightest medication changes can lead to breakthrough seizures, and medication switches can push a stable person living with mental illness into a health crisis.

The reality is that insurer-motivated medication switches can be a serious threat to patients’ stability, leading not only to serious health ramifications but also driving up societal and system-wide costs by requiring more inpatient and emergency health care, and causing lost productivity and possible job loss.

It stands to reason that since you can’t change your health insurance plan throughout the year, your insurer shouldn’t be able to change your pharmacy benefits. And while we certainly need to improve consumer protections to keep this insurance bait-and-switch from happening, it makes reviewing your health plan during open enrollment even more critical to protecting your health.

So take the time to take advantage of open enrollment. See what’s supposed to be covered in 2017 and get a better idea for coverage changes to look out for next year. Pay attention to details. Picking the right plan is worth the effort.


Michael Ruppal is executive director of The AIDS Institute, a national nonprofit dedicated to supporting and protecting health care access for people living with HIV/AIDS and other chronic diseases.

Morning Consult welcomes op-ed submissions on policy, politics and business strategy in our coverage areas. Submission guidelines can be found here.


Health Brief: GOP Senators Ask CBO to Fast-Track ACA Overhaul Review

Senate Republican leaders have asked the Congressional Budget Office to fast-track consideration of a plan from Sens. Lindsey Graham (R-S.C.) and Bill Cassidy (R-La.) to overhaul the Affordable Care Act. The CBO is reportedly in the process of analyzing the cost and coverage impact of the plan, as Republicans face pressure to make one last attempt at undoing the ACA before GOP senators’ ability to pass legislation with a simple majority expires on Sept. 30.

Health Brief: Week in Review & What’s Ahead

HELP Committee Chairman Lamar Alexander (R-Tenn.) hopes to reach a deal with Democrats on a plan to shore up the ACA exchanges early this week. A final agreement, if reached, is likely to extend key insurer payments, known as cost-sharing reductions, and include reforms to make it easier for states to establish reinsurance programs. Some Republicans are also pushing to give states more flexibility over required benefits in Obamacare plans, a proposal that is controversial with Democrats.

Health Brief: Some Moderate House Democrats Seek ACA Stabilization

While progressives this week rallied behind Sen. Bernie Sanders’ (I-Vt.) single-payer health care bill, a group of moderate House Democrats in the New Democrat Coalition aligned themselves with the Senate Health, Education, Labor and Pensions Committee’s bipartisan push to stabilize the Affordable Care Act exchanges, which Committee Chairman Lamar Alexander (R-Tenn.) aims to reach a final deal on by early next week.

Health Brief: Deal Reached to Extend CHIP Funding

Senate Finance Committee leaders reached a deal on a five-year reauthorization of the Children’s Health Insurance Program, in a win for children’s health advocates who are seeking longer-term funding certainty for the program, which will expire at the end of the month without congressional action. The deal also gradually phases out the enhanced federal share of funding for state CHIP programs, which was increased under the Affordable Care Act by 23 percentage points.

Health Brief: Some Navigators Shut Down Ahead of ACA Enrollment Period

Several navigator organizations, including one that received the largest federal grant for Obamacare enrollment activities in 2016, are suspending operations ahead of the 2018 open enrollment season because they haven’t received contracts for funding from the Department of Health and Human Services, which could cause enrollment to plummet. The Trump administration announced plans last month to cut funding for navigator groups by about 40 percent, but health officials haven’t said whether the grants would end altogether.

Health Brief: Teva Names New CEO

H. Lundbeck A/S’s Kaare Schultz was named as Teva Pharmaceutical Industries Ltd.’s new chief executive officer, ending a seven-month search by the world’s largest generic drug maker to find a new leader. Schultz could face pressure to split the company into two businesses, one focusing on patented specialty drugs and the other on cheap copycat medicines

Load More